It is recommended to rotate the injection site each week to prevent irritation and hard lumps from forming under the skin
Our findings offer comprehensive real-world evidence for the cardiovascular effectiveness of tirzepatide in clinical practice in the absence of studies with direct comparisons to semaglutide, and ahead of further evidence from the SURPASS-CVOT randomized controlled trial that compared tirzepatide against an older GLP-1 receptor agonist that is not frequently used in routine care 14,17
Retatrutide at the 12 mg dose produces approximately 28.7% body weight loss at 68 weeks, compared to 14.9% with semaglutide 2.4 mg at the same timepoint
placebo = 650) was to provide an effective power of 99% for the first 7 outcomes in the hierarchy
Prescription weight-management and diabetes medications are not appropriate for everyone and require individualized medical assessment, prescribing, monitoring, and follow-up
The same drug lists for $155 in Canada and just $59 in Germany